Hypofractionation has been demonstrated to be equally effective as standard conventional courses of radiation therapy in specific clinical situations. ASTRO supports the use of hypofractionated regimens in disease sites where the treating radiation oncologist determines it is a reasonable approach.
- ILROG Emergency Guidelines for Radiation Therapy of Hematological Malignancies – April 10, 2020
ASTRO/ESTRO Practice Recommendations for Risk-adapted Head and Neck Cancer Radiotherapy During the COVID-19 Pandemic – April 9, 2020
ASTRO/ESTRO Practice Recommendations for Lung Cancer Radiotherapy During the COVID-19 Pandemic – April 6, 2020
Recommendations for Prioritization, Treatment and Triage of Breast Cancer Patients During the COVID-19 Pandemic – April 1, 2020
NICE COVID-19 rapid guideline: delivery of radiotherapy – March 28, 2020
Radiation Therapy for the Whole-Breast – 2018
Hypofractionation for Localized Prostate Cancer – 2018
Tumor Radiobiology of SRS and SBRT – 2013
ASTRO has compiled a selection of resources for radiation oncology professionals. The resources were developed by clinical teams and based on the best available information at the time they were posted and may be outdated or superseded. Physicians, and their patients, must make the ultimate judgment regarding specific treatment decisions. They are not meant to replace clinical judgment, but to help treatment teams strengthen their clinical management of patients and support decision-making processes during the COVID-19 pandemic.
Last updated: 5/4/2020 12:54:54 PM